Pairing of individual splice sites during early recognition of pre-mRNAs is an attractive model for the orchestration of splicing in genes with multiple introns. Indeed, in Saccharomyces cerevisiae, direct support exists for the pairing of splice sites across introns during the first step of spliceosome assembly (4, 8, 30, 31) . In vertebrate pre-mRNAs, however, initial interaction between factors recognizing both ends of an intron is problematic because of the large size of many vertebrate introns. We have recently suggested that the exon is the unit of recognition during early spliceosome assembly in vertebrates with the concomitant pairing of splice sites across exons (29, 34) . Interactive binding of factors across exons is feasible in vertebrates because internal exons are quite small, rarely exceeding 300 nucleotides (10) .
Exon-intron architecture varies widely among eukaryotes. Although vertebrate exons are quite small and cannot be expanded without loss of recognition (29) , many genes in lower eukaryotes have large exons (10) . Most of these genes with large exons have small introns; however, some have large introns. If splice sites are paired, these genes have an awkward array of large and small distances between pairs of sites, making the mechanism of splice site recognition in these pre-mRNAs unclear. To address this problem, we have turned to the study of splice site recognition in Drosophila melanogaster. The majority of Drosophila exons are 100 to 180 nucleotides in length; however, 15% are more than 550 nucleotides, which is predicted to be too large to function in a vertebrate (10) . This difference suggests that pairing of splice sites across exons will not work for recognition of these large exons.
A comparison of intron sizes between vertebrates and Drosophila species also reveals another obvious difference from vertebrates. More than half of Drosophila introns have lengths of fewer than 80 nucleotides, with most having lengths in the range of 59 to 67 nucleotides (24) . These introns would be too small to function in a vertebrate (35) . Thus, there are a number of Drosophila genes that have large exons and small introns, which is an inverted exon-intron architecture compared with that found in vertebrate genes. The sequence of Drosophila introns also differs from that of vertebrate introns. * Corresponding author. Phone: (713) . Fax: (713) 796-9438. First, Drosophila introns tend not to have a G in the position preceding the branched nucleotide (24) . G is the most common nucleotide at this position in mammalian introns. Second, the pyrimidine-rich regions important for vertebrate splicing are frequently missing from the 3' end of Drosophila introns, especially in small introns (24) . In addition, Drosophila introns have a 17% higher A+T content than their flanking exons; vertebrates do not share this disparity (5, 24) .
One of the strongest pieces of evidence supporting the pairing of splice sites across exons in vertebrates is the phenotype of 5' splice site mutations. Such mutations inactivate the intron in which they reside in all organisms. When local cryptic sites are absent, however, 5' splice site mutations also suppress the splicing of the proximal upstream intron in vertebrates, resulting in a product RNA missing the exon bordered by the mutation (34) . A variety of such mutations in vertebrate genes have now been analyzed (for a review, see references 18 and 34). To date, however, no mutation of this type has been analyzed for RNA phenotype in a gene from a lower eukaryote containing large exons and multiple introns. If the intron is the unit of splice site pairing (or if splice sites are recognized independently), the predicted phenotype is intron inclusion. If the exon is the unit of recognition, the predicted phenotype is exon skipping.
In this report, we present three phenotypes that differentiate the splicing of a typical vertebrate pre-mRNA with small exons from that of a Drosophila pre-mRNA with small introns. First, introduction of a 5' splice site mutation into the second intron of the natural Drosophila zeste gene promoted inclusion of the mutated intron rather than exon skipping, when analyzed in vivo in Schneider 2 (S2) cells. Second, expanding the size of two small Drosophila introns inhibited wild-type splicing of these introns in vitro and promoted cryptic splice site utilization in vivo, such as to splice small versus large introns. Third, through the development of an in vitro Drosophila splicing system, we show that assembly of an initial ATP-dependent splicing complex required both ends of a Drosophila intron.
Together, these observations suggest mechanistic differences in the process of splice site selection in pre-mRNAs with small introns versus those with small exons. We suggest that splice sites are initially recognized as pairs across the shortest dis-
MATERIALS AND METHODS
Splicing substrates. The adenovirus substrates used in this study contained information from the human adenovirus late transcription unit based on the MINX transcript described previously by this laboratory (29) . adeno 62 (see Fig. 4A and 7B) was a derivative of the wild-type adenovirus duplication construct previously reported. DNA was truncated in the second intron with BglII to create a two-exon substrate. The 120-nucleotide first intron of the duplication construct was partially deleted by Bal 31 exonuclease digestion to produce a 62-nucleotide intron. The deletion was from +8 to +65 of the intron. adeno-X (see Fig. 7B ) was also derived from the adenovirus duplication construct. The 323-nucleotide BamHI fragment from the third intron of the human calcitonin/ calcitonin gene-related peptide (CGRP) gene was inserted at the HindIII site in intron 1 to create an expanded intron of 440 nucleotides. To synthesize RNA, substrates were truncated at the BglII site in the second intron. Thus, adeno 62 and adeno-X were identical substrates, except for the calcitonin/ CGRP sequences used to expand the intron.
The zeste in vitro substrates were derived from the natural Drosophila zeste gene (kindly provided by V. Pirrotta). zeste 62 (see Fig. 4A , SB, 6, and 7A) and zeste 62-5'MT (see Fig. 4A ) contained the second 62-nucleotide intron of zeste with flanking exon sequences. Twenty-five nucleotides of SP65 polylinker were fused to the last 48 nucleotides of zeste exon 2 to create the first exon of this substrate. The second exon in this construct was composed of the first 62 nucleotides of zeste exon 3. Substrates were truncated at the BamHI site 7 nucleotides downstream of zeste exon 3 sequences. The 5' splice site mutation is identical to that in the in vivo construct, zeste-5'MT, which is described below.
zeste 62A5 (see Fig. SB ) contained the isolated 3' splice site of the zeste second intron. The construct was made by deleting all of the exon 1 sequences of zeste 62 and the first 7 nucleotides (including the 5' splice site) of intron 2 by oligonucleotide-mediated PCR. Both zeste 62 and zeste 62A5 had identical sequences with the exception of this deletion. zeste-X (see Fig. 7A ) was derived from zeste 62 as well and contained identical sequence information, except for the intronic insertion in zeste-X. A 300-nucleotide fragment from intron 7 of the Drosophila troponin T gene was obtained by PCR and sequenced. Drosophila troponin T was kindly provided by E. Fyrberg. This fragment was cloned into the zeste 62 intron at nucleotide +7 of the intron. The insertion was downstream of the 5' splice site and upstream of the branch point, pyrimidine tract, and 3' splice site.
The substrate ZPE (see Fig. 6 ) was constructed by fusing zeste62A5 at the BamHI site downstream of the zeste exon sequences to the first 48 nucleotides of natural zeste exon 2 followed by the first 7 nucleotides of intron 2 containing the 5' splice site. Twenty-five nucleotides of SP65 polylinker were inserted by the cloning at the fusion site. This construction created a pseudoexon by fusing the 3' splice site to a downstream 5' splice site with exon sequences between. RNA was synthesized by truncating 12 nucleotides downstream of the 5' splice site with NcoI.
The substrate mle 59 (see Fig. 4A , 5A, 6, and 7A) contained the first 59-nucleotide intron from the Drosophila maleless gene, kindly provided by M. Kuroda, with the last 53 nucleotides of exon I and the first 95 nucleotides of exon 2. Thirty-two nucleotides of SP65 polylinker were fused upstream of the maleless exon 1 sequences. RNA was made by truncating at the HindIll site 5 nucleotides downstream of the exon 2 sequences. mle 59A5 (see Fig. SA ) was created by deleting all of the exon 1 sequences and the first 8 nucleotides of the intron using oligonucleotide-mediated PCR. This deleted the 5' splice site and left intact the 3' splice site region of the intron. mle-X (see Fig. 7A ) was constructed by inserting the same troponin T intron fragment used in zeste-X in the middle of the mle 59 intron. The fragment was inserted at nucleotide +33 of the intron. Other than the insertion, mle 59 and mle-X had identical sequence information. The pseudoexon substrate MPE (see Fig. 6 ) contained mle 59A5 sequences fused at the HindIII site downstream of exon 2 to the last 53 nucleotides of mle exon 1 and the first 27 nucleotides of intron 1. This created a structure similar to that of an exon with a 3' splice site fused to a 5' splice site downstream. Eleven nucleotides of polylinker were inserted by the cloning at the fusion site.
In vivo expression constructs. DNA plasmids containing the Drosophila zeste gene with its natural polyadenylation site were constructed as diagrammed in Fig. I (zeste-WT and zeste-5' MT). The last 470 nucleotides of zeste exon 1 were fused to the 300-nucleotide EcoRI-BamHI fragment from the Drosophila actin SC distal promoter. This fragment contained the first 88 nucleotides of actin exon 1. To create zeste-S'MT, a mutation was introduced at the 5' splice site beginning intron 2 by PCR-mediated cloning with oligonucleotides altered for 2 bases at this site; the canonical GT was changed to CG.
The following four expression constructs were derived from the natural zeste and maleless genes by utilizing fragments from previously cloned splicing substrates (described above). MXMG and ZXMG (see Fig. 2 ) were constructed by cloning mle-X and zeste-X into a Drosophila in vivo expression vector. mle-X and zeste-X were isolated for cloning by performing PCR with oligonucleotides hybridizing to the 5' and 3' ends of the substrates. Both mle-X and zeste-X were fused to the EcoRI-BamHI fragment of the Drosophila actin Sc distal promoter at nucleotide +88. Downstream, mle-X and zeste-X were fused to the last 1,445 nucleotides of the natural zeste gene (NaeI-HindIII fragment) containing zeste exon 3 sequences and the zeste polyadenylation signals.
M5Z3 and Z5M3 (see Fig. 3 Fig. 2 and 3 , the 5' and 3' oligonucleotides that were used in Fig. 1 were used.
Nuclear extracts and in vitro splicing assays. Drosophila S2 cell nuclear extracts were prepared according to procedures described by Dignam et al. (6) . RNA (Fig. 3A) . M5Z3 RNA produced two strong amplification product bands and several bands of weaker intensity (Fig. 3A, lane 4). The largest band (Fig. 3A [@] ) was of a size consistent with that of unspliced RNA (627 nucleotides) and electrophoresed at the same mobility as the band produced from PCR amplification of M5Z3 DNA (Fig. 3A, lane 5) . After sequencing, the smallest band of 234 nucleotides (Fig. 3A [0] ) was determined to be the result of wild-type splicing between the maleless 5' splice site and the zeste 3' splice site (see top of Fig.  3B ). The slightly larger band (290 nucleotides) of weaker intensity (Fig. 3A [+] ) was also sequenced. This product band was the result of activation of the same two internal cryptic splice sites used in the aberrant splicing event of the expanded zeste minigene (see the bottom of Fig. 2C ). Concomitantly, this M5Z3 RNA product contains three exons due to the removal of two introns (see the bottom of Fig. 3B ).
RT-PCR performed on RNA from the converse construct, Z5M3, produced two amplification products (Fig. 3A, lane 6 The larger band (Fig. 3A [@] ) was consistent with the predicted size for unspliced RNA (640 nucleotides) and electrophoresed at the same mobility as the band produced from PCR amplification of Z5M3 DNA (Fig. 3A, lane 7) . Direct sequencing of the slightly smaller band (Fig. 3A [A] ), which was not of a size predicted for wild-type splicing, demonstrated aberrant splicing. The zeste 5' splice site was spliced to a cryptic 3' splice site 92 nucleotides downstream in the intron (Fig. 3C) . This is the same 3' splice site that was utilized in the aberrant spliced product obtained from the expanded mle intron (Fig. 2B) . No evidence for splicing of the natural zeste 5' splice site to the maleless 3' splice site (289 nucleotides) in the Z5M3 minigene was observed.
Thus, the splicing phenotype observed was dictated by the 3' splice site. The relatively pyrimidine-poor mle 3' splice site supported no splicing of a large intron. Neither the intact 350-to 400-nucleotide-expanded intron nor the second 203-nucleotide intron that could have been created by recognition of the embedded pseudoexon was spliced. The largest intron removed among introns containing the mle 3' splice site was 112 nucleotides, suggesting an intron length maximum for the splicing of Drosophila introns with pyrimidine-poor 3' splice sites. In contrast, the zeste 3' splice site containing a 12-nucleotide uninterrupted pyrimidine tract was capable of directing a low level of splicing of 200-to 300-nucleotide introns. The zeste 3' splice site, however, was not sufficient to direct 100% splicing of a large intron, because RNA products resulting from activation of cryptic splice sites within the expansion unit were observed.
The cryptic 3' and 5' splice sites located within the expansion unit are not, to our knowledge, activated in the Drosophila minigene from which they originated. Inspection of the sequences in the cryptic 3' splice sites did not reveal strong homologies to the Drosophila 3' splice site consensus. The 5' splice site did have a reasonable fit to consensus. It should be noted that expanded introns containing the mle 3' splice site utilized the cryptic 3' splice site but ignored both the cryptic 5' splice site and its own 3' splice site. Presumably, this preference reflects a difficulty in removing the 203-nucleotide second was analyzed by RT-PCR amplification with the diagrammed oligonucleotide primers (arrows a and b) to determine splicing phenotypes. Primer a was complementary to actin sequences derived from the promoter; primer b was complementary to sequences within zeste exon 3. Amplification products were displayed on a native 10% polyacrylamide gel and then silver stained. The identities of individual bands were confirmed by direct sequencing. Amplification products were obtained by performing RT-PCR in the presence (lanes 2, 3, 4, and 6) or absence (lanes 8, 9, and 10) of reverse transcriptase. Thus, the product bands in lanes 4 and 6 were derived from RNA because in the absence of reverse transcriptase (lanes 8 to 10), these products were 5 ' splice site mutation as the minigene, zeste-5'MT, described in the legend to Fig. 1 . Splicing intermediates and products are indicated. These were identified by predicted sizes and changes in electrophoretic mobility on gels with differing percentages of acrylamide. Markers are MspI-digested pBR322 DNA. (B) The sequences of the maleless, zeste, and adeno introns assayed above. Note the presence of a long pyrimidine tract at the 3' end of both the adeno and the zeste introns and the lack of any discernible tract in the intron from maleless. Splicing signals, both 5' and 3', are a fairly strong match to the consensus splice site sequences shown above (24) . intron in a double splicing event and underscores the inability of the pyrimidine-poor mle 3' splice site to direct the splicing of an expanded intron.
In vitro splicing of small Drosophila introns. The contrasting in vivo splicing phenotypes of 5' splice site mutants in vertebrates and in Drosophila species and the observation of a size restriction for normal splicing of small Drosophila introns suggested a basic difference in the mechanism of recognition of splice sites in the two types of organisms. To begin to address this possibility, we developed an in vitro splicing system using a nuclear extract from Drosophila S2 cells. Initial experiments were performed to test the capabilities of the system. Figure  4A illustrates a time course of a standard splicing assay with several different precursor RNAs. zeste 62 and zeste 62-5'MT precursor RNAs contain, respectively, the wild-type or mutant 62-nucleotide second intron of zeste with its flanking exon sequences. These constructs are derived from the zeste minigenes that are analyzed for in vivo splicing in Fig. 1 to 3 . In the in vitro Drosophila system, zeste 62 precursor RNA was spliced efficiently, such that ligated product RNA was visible by 45 min of reaction. zeste 62-5'MT precursor RNA was inhibited for any splicing activity (Fig. 4A) . Thus, the S2 extract spliced wild-type RNA well and responded to mutation of a 5' splice site by blocking the first step of splicing.
A second, small, 59-nucleotide Drosophila intron from the maleless gene, mle 59, was also assayed in this system. It too was spliced, although in most experiments not to the efficiency of zeste (Fig. 4A) . However, splicing of small introns was not limited to introns from D. melanogaster. A 62-nucleotide adenovirus-based intron, adeno 62, was also spliced in the S2 extract (Fig. 4A) . All three small introns, zeste 62, mle 59, and adeno 62, were spliced with similar efficiencies. Although the three introns have similar sizes, their sequences are different (Fig. 4B) . Both adeno 62 and zeste 62 have pyrimidine-rich regions upstream of their 3' splice sites, with 13 and 12 pyrimidine stretches, respectively, unlike the mle 59 intron, which has a very low percentage of pyrimidines in the same region. Thus, the S2 extract is not dependent on a pyrimidinerich 3' splice site to splice small introns. This ability of Drosophila extracts to splice small pyrimidine-rich or pyrimidine-poor introns has been observed previously for extracts from Drosophila Kc cells (9, 28) .
The four constructs containing small introns, zeste 62, zeste 62-5'MT, adeno 62, and mle 59, were also assayed in HeLa extract, instead of S2 nuclear extract. As expected, these substrates were completely inactive for splicing, presumably because the introns fall below the minimum length requirement for vertebrate splicing (35) (data not shown). The Drosophila extract was not limited to splicing small introns. Larger adenovirus-based introns of 120 and 440 nucleotides were assayed in S2 extract. Both were accurately spliced, but with a slight decrease in efficiency as the intron size became larger (data not shown). Therefore, the in vitro S2 splicing system that we have developed is competent to splice introns of moderate size as well as introns that are too small to function in a vertebrate.
Assembly of Drosophila early-splicing complexes requires both ends of the intron. Vertebrate precursor RNAs containing a single intron assemble into multiple specific ATPdependent complexes when splicing reactions are displayed on native gels (for a review, see reference 23). These complexes appear subsequent to one another in a time-dependent manner. Formation of the first complex, complex A, requires the presence of a 3' splice site but is independent of the presence of a complete intron using constitutive 3' splice sites (3, 7, 16, 21) . Vertebrate precursor RNAs containing either a complete intron or only a 3' splice site rapidly assembled complex A in our Drosophila S2 extract, indicating that assembly of complex A could be supported by a vertebrate 3' splice site in both HeLa and Drosophila cell extracts (data not shown).
To examine the requirements for assembly of Drosophila introns, splicing reactions of precursor RNAs containing introns from the Drosophila maleless (59-nucleotide) and zeste (62-nucleotide) genes were displayed on native gels (Fig. SA  and B, respectively) . Wild-type mle 59 and zeste 62 both directed assembly of an ATP-dependent complex by 2 min of reaction. Presumably, this complex is the Drosophila analog of the vertebrate A complex. Recent evidence by Spikes and Bingham (32) demonstrated that the complex A that is formed in Drosophila embryo extract contains U2 small nuclear RNA and unspliced precursor RNA, similarly to complex A in vertebrates. Indeed, in our assay the Drosophila complex showed migration on gels similar to that of the A complex assembled on an adenovirus precursor RNA in Drosophila S2 extract (data not shown).
The appearance of the maleless and zeste complex A was dependent on the 5' splice site beginning the intron. Deletion of the 5' splice site beginning the intron in mle 59A5 (Fig. SA) MOL. CELL. BIOL. ) containing either all or the 3' half of a functional intron were incubated in a Drosophila extract splicing assay for the indicated times. The assembled complexes were resolved on a native ribonucleoprotein gel. Well-resolved higher-order complexes were never detected in these assays. The numbers to the left of the 3' splice sites in mle 59A5 and zeste 62A5 represent the number of nucleotides from the natural intron remaining after deletion of the 5' splice site. (C and D) The amounts of complex A in panels A and B, respectively, quantitated and plotted versus incubation time.
or zeste 62A5 (Fig. 5B) depressed assembly of the complex. Quantitation of complex formation for the mle and zeste substrates (Fig. 5C and D, respectively) Drosophila zeste and maleless small introns were more dependent on the presence of a complete intron than comparable vertebrate 3' splice sites. Furthermore, the assembly properties of these 3' splice sites were similar to those observed with S. cerevisiae splice sites, in which intact introns are required to observe ATP-dependent complex formation (4, 31) .
Assembly of an isolated exon requires a pyrimidine-rich 3' splice site. Because the presence of pyrimidines in a 3' splice site permitted splicing of an expanded intron in vivo, we were interested in determining whether a pyrimidine tract would permit a Drosophila 3' splice site to assemble an ATPdependent complex when presented to the extract as an exon, rather than as an intron or an isolated 3' splice site. In Fig. 5 , we demonstrated that isolated 3' splice sites from maleless and zeste were severely depressed for assembly of complex A compared with intact introns containing both 5' and 3' splice sites. We then asked if placing a 5' splice site downstream of the 3' splice site (creating a pseudoexon) would have a similar effect. More importantly, we asked if there is a difference in directing spliceosome assembly between the maleless and zeste 3' splice sites.
To address these questions, two in vitro substrates, ZPE and MPE, were constructed. These substrates contained either the zeste (ZPE) or maleless (MPE) 3' splice site with flanking exon sequences fused to its cognate 5' splice site, normally upstream across the intron, now placed downstream to create a pseudoexon structure (Fig. 6) . The constructs were assayed for their ability to assemble complex A in a standard splicing reaction with S2 extract. The reaction products were displayed on a native agarose-acrylamide gel. Considerable complex A was observed for the zeste exon but not for the mle exon. The mle exon assembled no visible complex A, even after 30 min of reaction. The zeste exon was competent to assemble at virtually the same efficiency as the zeste intron. Therefore, the zeste 3' splice site containing a pyrimidine-rich region was able to direct assembly of complex A when the zeste 5' splice site was placed either upstream across an intron or downstream across an exon. In contrast, the maleless 3' splice site without a pyrimidine stretch was competent for assembly only when paired with a 5' splice site across an intron.
Assembly of splicing complexes is depressed for expanded small introns. Expansion of the small zeste and maleless introns promoted aberrant splicing phenotypes in vivo, as seen in Fig. 2 . These data suggested that the splicing machinery preferred to select splice sites in pairs across the shortest distance. To examine this at an early stage of assembly, two expanded intron substrates for in vitro analysis were constructed by using the maleless and zeste introns to create mle-X and zeste-X, respectively. The exon and intron sequences in these constructs were identical to those in the expanded intron constructs used in vivo. mle-X and zeste-X were first assayed for their abilities to assemble into splicing complexes in S2 nuclear extract along with their naturally small parent constructs, mle 59 and zeste 62 (Fig. 7A ). Both mle-X and zeste-X were depressed for the formation of complex A compared with mle 59 and zeste 62. Quantitation of this assay revealed that complex A assembly was depressed 15-fold for zeste-X and to nondetectable levels for mle-X. The inhibition of complex A formation in mle-X and zeste-X is not due to an inability of the S2 extract to recognize large introns, because expansion of a small adenovirus-based intron from 62 (adeno 62) to 440 (adeno-X) nucleotides in length produced only a twofold reduction of spliceosome assembly in this extract (Fig. 7B) . Therefore, the inhibition of complex assembly due to increasing the size of a small intron is specific for Drosophila introns and not for adenovirus-based (vertebrate-like) introns.
The three expanded intron substrates, mle-X, zeste-X, and adeno-X, were also assayed in a standard splicing assay with S2 nuclear extract. No splicing activity was detected for either mle-X or zeste-X; however, adeno-X was accurately spliced, but only at a moderate efficiency (data not shown). Thus, expanding a small Drosophila intron effectively reduced its ability to be recognized by the splicing machinery as assayed for assembly and splicing in vitro. These results were in agreement with our earlier in vivo observations of size restrictions for the recognition of small Drosophila introns.
DISCUSSION
Interactions between splice sites have been implicated during early spliceosome assembly in both S. cerevisiae and vertebrates (4, 29, 31) . In yeasts, sites are paired across the intron; in vertebrates, pairings across both exons and introns have been postulated. In lower eukaryotes, introns are often smaller than exons; in vertebrates, the reverse is true (10) . We began the present study with the hypothesis that splice sites could be paired across either introns or exons, depending on which distance is shorter, and that certain splicing consensus sequences might dispose a given splice site to pair with the opposite site across either the intron or the exon. To examine this hypothesis, we chose to characterize the splicing properties of introns from an organism which we predicted might pair splice sites across both introns and exons. Genes from D. melanogaster were analyzed because they contain both small and large exons and introns, presenting a variety of possibilities for splice site pairing. This report represents the first stage of this analysis in which we examined the requirements for the assembly and splicing of small introns in Drosophila premRNAs.
Intron inclusion. One of the distinguishing properties observed for Drosophila genes with small introns was the phenotype of a 5' splice site mutation bordering an internal exon. The Drosophila zeste gene that we characterized has two small introns and three large exons. Mutation of the 5' splice site bordering the internal exon resulted in 100% intron inclusion in vivo, with no observable exon skipping or activation of a cryptic 5' (32) , intact intron (9, 28, 32) , and expand intron (in vivo) (12) . dine tract within the zeste 3' splice site. The converse is also true. Expansion of the pyrimidine-poor white intron with a copia element permits some wild-type splicing in vivo; however, the insertion does depress overall splicing of this intron (20, 25, 36) . More extensive mutational analysis of Drosophila splicing signals from small and large introns will be required to determine which elements are required for efficient processing of large introns.
Spliceosome assembly. In support of mechanistic differences between the recognition of splice sites in pre-mRNAs with small introns versus large introns, we observed that in vitro assembly of Drosophila spliceosome complex A required sequences at both ends of the zeste and mle introns, in contrast to vertebrate assembly of complex A, which required only sequences at the 3' end of the intron with a minimal amount of flanking exon sequence (3, 7, 16, 21) . The zeste and mle assembly requirements for intact introns are similar to those observed for S. cerevisiae (4, 31) . Surprisingly, assembly of complex A on the small maleless and zeste introns required sequences different from those necessary for complex formation on the larger, 150-nucleotide intron from the Drosophila fushi tarazu (ftz) gene (32) . The ftz 3' splice site contains an 11-nucleotide uninterrupted pyrimidine tract. The isolated 3' splice site from ftz assembles complex A, similarly to a vertebrate 3' splice site. Moreover, the efficiencies of complex formation on the ftz isolated 3' splice site and intact intron are nearly identical. Thus, the ftz intron exhibits properties similar to those of a vertebrate intron. In vivo, the ftz intron tolerates considerable expansion (greater than 2 kb), again reminiscent of vertebrate pyrimidine-rich introns (12, 32) . Inspection of ftz 3' splice site sequences does not reveal an obvious difference between these sequences and that of the 3' splice site of zeste, in that both introns have uninterupted pyrimidine tracts. Mutational analysis of both 3' splice sites should yield interesting clues as to the features of a 3' splice site necessary for the splicing of large introns and/or exon definition.
Interestingly, although the zeste 3' splice site was unable to support ATP-dependent complex formation, we observed that VOL. 14, 1994 on April 21, 2014 by PENN STATE UNIV http://mcb.asm.org/ Downloaded from it directed formation of considerable complex A when a 5' splice was present downstream, such that it created an isolated internal exon. Therefore, this 3' splice site directed ATPdependent complex formation when present as either an exon or an intron. Strikingly, the pyrimidine-poor 3' splice site from maleless was not rescued for assembly by addition of a downstream 5' splice site; it could assemble only when present within an intron. Thus, the pyrimidine content of the 3' splice site may be crucial in maintaining the balance between selecting splice sites across introns and/or exons in Drosophila genes with multiple introns.
Splice site pairing. We have summarized the data presented here in Fig. 8 by displaying the distinguishing splicing and assembly properties of three Drosophila introns. We propose from our observations that splice sites can be paired across either introns or exons. It is unclear if distance between sites is the dominant determinant of the pairing pathway or if splice site consensus sequences contribute. The ability of a pyrimidine-rich 3' splice site to assemble both an intron and an exon reported here suggests that pyrimidine stretches and the factors that recognize them may influence the pairing pathway. In this regard, it will be interesting to examine the processing of pre-mRNAs that are transcribed from genes with a mixed exon-intron architecture. A few examples of genes of this type in Drosophila species include notch (14) , abelson (11) , and lethal (2) giant larvae (13) . Their mixed architecture suggests that both intron-based and exon-based recognition mechanisms could operate in a single pre-mRNA. The mechanism whereby this is possible remains unclear. Mutation of 5' splice sites within genes such as notch and abelson may help sort out these questions.
